Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy Robson

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 18, 2016
Transcending epithelial and intracellular biological barriers; a prototype DNA delivery deviceJoanne McCaffrey, Cian M McCrudden, Ahlam A Ali, et al.
Acta Biomaterialia|July 13, 2019
DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigenGrace Cole, Ahlam A Ali, Emma McErlean, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathwayLana McClements, Anita Yakkundi, Angelos Papaspyropoulos, et al.
Research in Social & Administrative Pharmacy : RSAP|September 6, 2021
Educating pharmacy students through a pandemic: Reflecting on our COVID-19 experienceJudith Strawbridge, John C Hayden, Tracy Robson, et al.
Journal of Thrombosis and Haemostasis : JTH|October 21, 2023
Glycolytic reprogramming fuels myeloid cell-driven hypercoagulabilityAisling M Rehill, Gemma Leon, Sean McCluskey, et al.
Frontiers in Endocrinology|June 21, 2021
FKBPL and SIRT-1 Are Downregulated by Diabetes in Pregnancy Impacting on Angiogenesis and Endothelial FunctionAbdelrahim Alqudah, Kelly-Ann Eastwood, Djurdja Jerotic, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 5, 2014
Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene deliveryHelen O McCarthy, Joanne McCaffrey, Cian M McCrudden, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 14, 2015
FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesisAnita Yakkundi, Rachel Bennett, Ivette Hernández-Negrete, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanismAndrea Valentine, Martin O'Rourke, Anita Yakkundi, et al.
Reproductive Biology and Endocrinology : RB&E|March 10, 2010
Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control studyOlaf Sunnotel, Laszlo Hiripi, Kevin Lagan, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 18, 2016
Transcending epithelial and intracellular biological barriers; a prototype DNA delivery deviceJoanne McCaffrey, Cian M McCrudden, Ahlam A Ali, et al.
Acta Biomaterialia|July 13, 2019
DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigenGrace Cole, Ahlam A Ali, Emma McErlean, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathwayLana McClements, Anita Yakkundi, Angelos Papaspyropoulos, et al.
Research in Social & Administrative Pharmacy : RSAP|September 6, 2021
Educating pharmacy students through a pandemic: Reflecting on our COVID-19 experienceJudith Strawbridge, John C Hayden, Tracy Robson, et al.
Journal of Thrombosis and Haemostasis : JTH|October 21, 2023
Glycolytic reprogramming fuels myeloid cell-driven hypercoagulabilityAisling M Rehill, Gemma Leon, Sean McCluskey, et al.
Frontiers in Endocrinology|June 21, 2021
FKBPL and SIRT-1 Are Downregulated by Diabetes in Pregnancy Impacting on Angiogenesis and Endothelial FunctionAbdelrahim Alqudah, Kelly-Ann Eastwood, Djurdja Jerotic, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 5, 2014
Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene deliveryHelen O McCarthy, Joanne McCaffrey, Cian M McCrudden, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 14, 2015
FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesisAnita Yakkundi, Rachel Bennett, Ivette Hernández-Negrete, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanismAndrea Valentine, Martin O'Rourke, Anita Yakkundi, et al.
Reproductive Biology and Endocrinology : RB&E|March 10, 2010
Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control studyOlaf Sunnotel, Laszlo Hiripi, Kevin Lagan, et al.
Pageof 8